SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder

NCT01718483 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

383

Enrollment

INDUSTRY

Sponsor class

Conditions

Binge Eating Disorder

Interventions

DRUG: SPD489 (Lisdexamfetamine dimesylate)
DRUG: Placebo

Sponsor

Shire